<P>&nbsp;</P> <P align=justify><STRONG>The BioVision Investor Conference was held at the end of March at the Lyon Chamber of Commerce and Industry (CCI),</STRONG> as part of the <A title="" href="https://www.aderly.com/biovision_classemondiale/index,p,159,EN.jsp" target=_blank>8th edition of BioVision, the World Life Sciences Forum</A>. This event, which brought together 200 attendees, was organized in partnership with Aderly, Lyonbiop&#244;le and the Lyon CCI. During this evening networking event, <STRONG>promising foreign companies in the life sciences sector had the opportunity to talk with active investors and major industrial groups in the healthcare field</STRONG>. The event aimed to foster the setup of partnerships and to fund the development and growth of the companies taking part.</P> <P align=justify><BR>The BioVision Investor Conference is based on a <STRONG>partnership with four types of players: <A title="" href="https://www.aderly.com/lyon-biopole-pole-centre-recherche-scientifique/index,p,98,EN.jsp" target=_blank>Lyonbiop&#244;le</A>, France Biotech, a community of investors from Europe and around the globe, and BioVision&#8217;s international network.</STRONG></P> <P align=justify><BR>The participation of Aderly-Invest in Lyon, a partner in the BioVision Investor Conference, aimed to directly promote the region and the Life Sciences sector to SMEs and major international companies via the <STRONG><STRONG><A title="" href="https://www.aderly.com/services-aderly/index,p,100003,EN.jsp" target=_blank>full range of company setup services offered by the Agency</A></STRONG></STRONG>.<BR></P>